<?xml version="1.0" encoding="UTF-8"?><!-- generator="WordPress/2.8.4" -->
<rss version="0.92">
<channel>
	<title>HIStalk</title>
	<link>http://histalk2.com</link>
	<description>Healthcare IT News and Opinion</description>
	<lastBuildDate>Fri, 06 Nov 2009 02:59:22 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>News 11/6/09</title>
		<description>         From Ryan Nichols: “Re: CIO salaries. In 2004, you posted salary data for a number of CIOs, including some fairly high ones like Shands. How accurate was that data? Was there some other reason for some salaries to be off the ...</description>
		<link>http://histalk2.com/2009/11/05/news-11609-2/</link>
			</item>
	<item>
		<title>News 11/4/09</title>
		<description>         From The PACS Designer: “Re: Windows 7. Microsoft has released a 90-day trial copy of Windows 7 for IT professionals to use in testing Windows 7.”         From Charles Chips: “Re: road rage story. ...</description>
		<link>http://histalk2.com/2009/11/03/news-11409-2/</link>
			</item>
	<item>
		<title>Readers Write 11/2/09</title>
		<description>Submit your article of up to 500 words in length, subject to editing for clarity and brevity (please note: I run only original articles that have not appeared on any Web site or in any publication and I can’t use anything that looks like a commercial pitch). I’ll use a ...</description>
		<link>http://histalk2.com/2009/11/02/readers-write-11209/</link>
			</item>
	<item>
		<title>Monday Morning Update 11/2/09</title>
		<description>         From HISJunkie: “Re: InfoLogix. Looks like they are on their last breath. Never did think this outfit would make it. They always seemed kind of shifty to me -- did the Wall Street dance, pumped it up, took it public, made ...</description>
		<link>http://histalk2.com/2009/10/31/monday-morning-update-11209-2/</link>
			</item>
	<item>
		<title>News 10/30/09</title>
		<description>From HITGhost: “Re: Aspyra. It voluntarily delists itself from NYSE Amex.” The market cap of the LIS/PACS vendor is down to $1.4 million, so obviously it’s not worth the administrative cost to stay publicly traded.

From UKnowMe: “Re: Accenture. I hear that Accenture is eliminating its healthcare practice over the next ...</description>
		<link>http://histalk2.com/2009/10/29/news-103009/</link>
			</item>
</channel>
</rss>
